Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000482713 | SCV000565016 | uncertain significance | not provided | 2021-04-23 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 28356264) |
Invitae | RCV001083373 | SCV000771081 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000482713 | SCV001155256 | uncertain significance | not provided | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002402376 | SCV002707058 | likely benign | Cardiovascular phenotype | 2023-04-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV003150235 | SCV003837893 | likely benign | Cardiomyopathy | 2022-02-24 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003993977 | SCV004813855 | likely benign | not specified | 2024-02-05 | criteria provided, single submitter | clinical testing | Variant summary: FLNC c.1568T>C (p.Val523Ala) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00021 in 249522 control chromosomes (gnomAD). The observed variant frequency is approximately 27 fold of the estimated maximal expected allele frequency for a pathogenic variant in FLNC causing Dilated Cardiomyopathy phenotype (7.8e-06), strongly suggesting that the variant is benign. c.1568T>C has been reported in the literature in individuals affected with Dilated Cardiomyopathy without strong evidence of causality (Lenarduzzi_2023, Pham_2023). These reports do not provide unequivocal conclusions about association of the variant with Dilated Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 36788754, 37199186). ClinVar contains an entry for this variant (Variation ID: 418216). Based on the evidence outlined above, the variant was classified as likely benign. |
Clinical Genetics, |
RCV000482713 | SCV001921697 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000482713 | SCV001930783 | uncertain significance | not provided | no assertion criteria provided | clinical testing |